Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

Salarius Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Salarius Pharmaceuticals, Inc.

Jan-07
Salarius Pharmaceuticals Changes Corporate Name to Decoy Therapeutics and Nasdaq Ticker Symbol to DCOY Reflecting Focus on Next-Generation Peptide Conjugate Therapeutics GlobeNewswire
Dec-19
Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting GlobeNewswire
Dec-18
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform GlobeNewswire
Dec-01
Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study GlobeNewswire
Nov-19
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol "SLRX" GlobeNewswire
Nov-13
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger GlobeNewswire
Oct-13
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements GlobeNewswire
Sep-09
Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire
Aug-14
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split GlobeNewswire
Jul-14
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq's Stockholders' Equity Standard GlobeNewswire
Jul-09
Salarius Pharmaceuticals' Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies GlobeNewswire
Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)